Skip to content
Riskpilot
← Back to search
Sign in
Get full access
Scandinavian Pharmaceuticals-Generics Aktiebolag
AB
Active
Org 5562293794
Activities of holding companies
· NACE 6421
Est. 1983
0 employees
Watchlist
Share
Sweden
/
Companies
/
Activities of holding companies
/
Scandinavian Pharmaceuticals-Generics Aktiebolag
Overview
Financials
People & ownership
Related companies
Loading company…
People & ownership
Management
Actively employed in the business
Name
Role
Member since
Current (1)
AP
Arne Pontus Pålsson
Chief Auditor
Chief Auditor
2020
Board of directors
Non-executive oversight
Name
Role
Member since
Current (3)
BC
Bernard Christiaan Spoelstra
Chairman
2024
JF
Jenny Friberg
Board of Directors
2020
JS
Jan-Christer Stefan Engryd
Board of Directors
2024
Former (5)
LH
Lars Henrik Andreas Rejnus
Chairman
2022 – 2024
CR
Caroline Rebecca Louise Dixon
Board of Directors
2022 – 2024
JJ
Jose Javier Cotarelo
Deputy Board Member
2020 – 2021
VS
Vidar Sie
Chairman
2020 – 2022
LR
Luis Rodolfo Birbuet
Board of Directors
2021 – 2023
Shareholders
As of last annual report
Shareholder
Type
Ownership
Votes
Since
Meda Aktiebolag
Company
100%
100%
0001
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive.
Learn more
.
More on Scandinavian Pharmaceuticals-Generics Aktiebolag
Overview →
Headline figures, risk assessment and company summary
Financials & key figures →
Revenue, EBITDA, balance sheet and 5-year trend
Related companies →
Corporate hierarchy, parent and subsidiary network
